Lipid nanoparticles (Solid lipid nanoparticles and nanostructured lipid carriers) for cosmetic, dermal, and transdermal applications

Nanoparticulate Drug Delivery Systems

Volumn , Issue , 2007, Pages 213-233

  Souto, Eliana B ^a   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132520392     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (92)

1. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999; 184:1-6.
2. Müller RH, Lucks J-S. Azneistoffträger aus festen Lipidteilchen-feste Lipid Nanosphären (SLN), Germany. European Patent 0605497, 1996.
3. Müller RH, Mäder K, Lippacher A, Jenning V. Fest-flüssig (halbfeste) Lipidpartikel und Verfahren zur Herstellung hochkonzentrierter Lipidpartikeldispersionen. PCT application PCT/EP00/04565, 1998.
4. Müller RH, Mehnert W, Souto EB. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery. In: Bronaugh L, ed. Percutaneous Absorption. New York: Marcel Dekker, 2005:719-738.
5. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54:S131-S155.
6. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of art. Eur J Pharm Biopharm 2000; 50:161-177.
7. Siekmann B, Westesen K. Submicron lipid suspensions (solid lipid nanoparticles) versus lipid nanoemulsions: similarities and differences. In: Benita S, ed. Submicron Emulsions in Drug Targeting and Delivery. Amsterdam: Harwood Academic Publishers, 1998:205-218.
8. Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002; 242:121-128.
9. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles and nanostructured lipid carriers. In: Nalwa HS, ed. Encyclopedia of Nanoscience and Nanotechnology. Los Angeles, California: American Scientific Publishers, 2004:43-56.
10. Müller RH, Wissing SA. Lipopearls for topical delivery of active compounds and controlled release. In: Rathbone MJ, Hadgraft J, Roberts MS, eds. Modified-Release Drug Delivery Systems. New York: Marcel Dekker, 2003:571-587.
11. Mehnert W, Mäder K. Solid lipid nanoparticles-production, characterization and applications. Adv Drug Deliv Rev 2001; 47:165-196.
12. Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996; 129:159-173.
13. Hunter RJ. Foundations of Colloidal Science. Oxford: Oxford University Press, 1986.
14. Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm 1995; 115:129-131.
15. Hagemann JW. Thermal behaviour and polymorphism of acylglycerides. In: Garti N, Sato K, eds. Crystallization and Polymorphism of Fats and Fatty Acids. New York: Marcel Dekker, 1988:9-96.
16. Hernqvist L. Crystal structures of fats and fatty acids. In: Garti N, Sato K, eds. Crystallization and Polymorphism of Fats and Fatty Acids. New York: Marcel Dekker, 1988:97-137.
17. Müller BW. Suppositorien. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1986.
18. Krischner H. Einführung in die Röntgenfeinstrukturanalyse. Vol. 4. Auflage: Vieweg Verlag Braunschweig, 1990.
19. Westesen K, Bunjes H, Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 1997; 48:223-236.
20. Speiser P. Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 0167825, 1990.
21. Domb AJ. Lipospheres for controlled delivery of substances. USP Patent USS 188837, 1993.
22. Müller RH, Lucks JS. Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN), 1991.
23. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US Patent 5,250,236, 1993.
24. Hallberg D, Holm I, Obel AL, Schuberth O, Wretlind A. Fat emulsion for complete intravenous nutrition. Postgrad Med 1967; 42:A149-A152.
25. Wretlind A. Development of fat emulsions. J Parenter Enteral Nutr 1981; 5:230-235.
26. Wretlind A. Recollections of pioneers in nutrition: landmarks in the development of parenteral nutrition. J Am Coll Nutr 1992; 11:366-373.
27. Cavalli R, Caputo O, Marengo E, Pattarino F, Gasco MR. The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Die Pharmazie 1998; 53:392-396.
28. Cavalli R, Marengo E, Rodriguez L, Gasco MR. Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996; 43:110-115.
29. Sjöström B, Bergenståhl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 1992: 88:53-62.
30. Fessi C, Devissaguet J-P, Puisieux F, Thies C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent 5,118,528, 1992.
31. Quintanar-Guerrero D, Fessi H, Alléman E, Doelker E. Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially-water-miscible solvents by distillation. Int J Pharm 1999; 188:155-164.
32. Heurtault B, Saulnier P, Pech B, Proust J-E, Richard J, Benoit J-P. Nanocapsules lipidiques, procédé de préparation et utilisation comme médicament, France, 2000.
33. Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002; 19:875-880.
34. Siekmann B, Westesen K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 1996; 43:104-109.
35. Reithmeier H, Herrmann J, Göpferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 2001; 218:133-143.
36. García-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloid Surf B 2002; 27:159-168.
37. Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm 2003; 55:125-131.
38. Dubes A, Parrot-Lopez H, Abdelwahed W, et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 2003; 55:279-282.
39. Hu FQ, Yuan H, Zhang HH, Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physi-cochemical characterization. Int J Pharm 2002; 239:121-128.
40. Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004; 273:29-35.
41. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003; 257:153-160.
42. Shahgaldian P, Gualbert J, Aïssa K, Coleman AW. A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur J Pharm Biopharm 2003; 55:181-184.
43. Heurtault B, Saulnier P, Pech B, et al. The influence of lipid nanocapsule composition on their size distribution. Eur J Pharm Sci 2003; 18:55-61.
44. Souto EB. SLN and NLC for topical delivery of antifungals. Ph.D. Thesis. Berlin: Free University of Berlin, 2005.
45. Mehnert W, zur Mühlen A, Dingler A, Weyhers H, Müller RH. Solid lipid nanoparticles (SLN)-ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. II. Wirkstoff-Inkorporation, Freisetzung und Sterilizierbarkeit. Pharm Ind 1997; 59:511-514.
46. zur Mühlen A. Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitsabilität, Charakterisierung, Freisetzungsverhalten und Mechanismen. Ph.D. Thesis. Berlin: Freie Universität Berlin, 1996.
47. Lukowski G, Werner U. Investigation of surface and drug release of solid lipid nanoparticles loaded with acyclovir. Int Symp Control Release Bioact Mater 1998; 25:425-428.
48. Jenning V. Feste Lipid-Nanopartikel (SLN) als Trägersystem für die dermale Applilkation von Retinol. Ph.D. Thesis. Berlin: Freie Universität Berlin, 1999.
49. Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000; 66:115-126.
50. Souto EB, Wissing SA, Barbosa CM, Müller RH. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 2004; 58:83-90.
51. Souto EB, Müller RH. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Die Pharmazie.
52. Wissing SA, Lippacher A, Müller RH. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 2001; 52:313-324.
53. Souto EB. SLN and NLC as drug carriers of clotrimazole for topical formulations. Master Thesis. Oporto: Oporto University, 2003.
54. Müller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004; 113:151-170.
55. Müller RH, Dingler A, Weyhers H, zur Mühlen A, Mehnert W. Solid lipid nanoparticlesein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 3. Mitteilung: Langzeitstabilität, Gefrier- und Sprühtrocknung, Toxizität, Anwendung in Kosmetika und Pharmazeutika. Pharm Ind 1997; 59:614-619.
56. Dingler A, Hildebrand G, Niehus H, Müller RH. Cosmetic anti-aging formulation based on vitamin E-loaded solid lipid nanoparticles. Proc Int Symp Control Release Bioact Mater 1998; 25:433^34.
57. Souto EB, Müller RH. Lipid nanoparticles (SLN and NLC) for drug delivery. In: Domb AJ, Tabata Y, Ravi Kumar MNV, Farber S, eds. Nanoparticles for Pharmaceutical Applications. Los Angeles, California: American Scientific Publishers, 2007:103-122.
58. Müller RH, Mehnert W, Lucks J-S, et al. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995; 41:62-69.
59. Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul 1999; 16:205-213.
60. Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278:71-77.
61. Weyhers H. Feste Lipid Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation, Herstellung, Charakterisierung oberflächenmodifizierter Formulierungen. Ph.D. Thesis. Berlin: Freie Universität Berlin, 1995.
62. Almeida AJ, Runge S, Müller RH. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 1997; 149:255-265.
63. zur Mühlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Die Pharmazie 1998; 53:552-555.
64. zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 1998; 45:149-155.
65. Sakuma S, Suzuki N, Sudo R, Hiwatari K, Kishida A, Akashi M. Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin. Int J Pharm 2002; 239:185-195.
66. Dingler A. Feste Lipid-Nanopartickel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation. Ph.D. Thesis. Berlin: Freie Universität Berlin, 1998.
67. Müller RH, Dingler A. Feste Lipid-Nanopartikel (Lipopearls(tm)) als neuartiger Carrier für kosmetische und dermatologische Wirkstoffe. Pharm Zeit Dermo 1998; 49:11-15.
68. Souto EB, Müller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005; 22:501-510.
69. Dingler A, Lukowski G, Pflegel P, Müller RH, Gohla S. Production and characterization of Lipopearls for cosmetics. Proc Int Symp Control Release Bioact Mater 1997; 25:935-936.
70. Wissing SA, Müller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 2002; 242:377-379.
71. de Vringer T. Topical preparation containing a suspension of solid lipid particles. European Patent 91200664, 1992.
72. Teeranachaideekul V, Souto EB, Müller RH, Junyaprasert VB. Effect of surfactant on the physical and chemical stability of ascorbyl palmitate-loaded NLC system. In: AAPS annual meeting and exposition, Nashville, U.S.A., November 2005:6-10.
73. Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Long-term physical stability of Q10-loaded NLC at different storage conditions. In: AAPS annual meeting and exposition, Nashville, U.S.A., November 2005:6-10.
74. Souto EB, Teeranachaideekul V, Junyaprasert VB, Müller RH. Encapsulation of nicotinamide into nanostructured lipid carriers. In: 15th international symposium on microencapsulation, Parma, Italy, September 2005:18-21.
75. Wissing SA. SLN als innovatives Formulierungskonzept für pflegende und protective dermale Zubereitungen. Ph.D. Thesis. Berlin: Freie Universität Berlin, 2002.
76. Wissing SA, Müller RH. The development of an improved carrier system for sunscreens formulations based on crystalline lipid nanoparticles. Int J Pharm 2002; 242:373-375.
77. Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002; 81:225-233.
78. Wissing SA, Müller RH. In vitro and in vivo skin permeation of sunscreens from solid lipid nanoparticles (SLN(tm)), supercooled melts and emulsions. In: Proceedings of the fourth world meeting APGI/APV, Florence, 2002:1135-1136.
79. Wissing SA, Müller RH. A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int J Cosmet Sci 2001; 23:233-243.
80. Wissing SA, Müller RH. Solid lipid nanoparticles (SLN) as sunscreens: advantages over conventional emulsion based systems. Proc Int Symp Control Release Bioact Mater 2001; 28:522-523.
81. Mariani E, Neuhoff C, Bargagna A, et al. Synthesis, in vitro percutaneous absorption and phototoxicity of new benzylidene derivatives of 1,3,3-trimethyl-2-oxabicyclo(2.2.2) octan-6-one as potential UV sunscreens. Int J Pharm 1998; 161:65-73.
82. Saupe A. Pharmazeutisch-kosmetische Anwendungen Nanostrukturierter Lipidcarrier (NLC): Lichtschutz und Pflege. Ph.D. Thesis. Berlin: Freie Universität Berlin, 2004.
83. Bennat C. Lichtschutz mit Mikropigmenten-Beitrag zur physikochemischen Charakterisierung, galenischen Stabilisierung und Untersuchung des Penetrationsverhaltens von mikrofeinen Titandioxid und Zinkdioxid. Ph.D. Thesis. Braunschweig: TU Braunschweig, 1999.
84. Bennat C, Müller-Gowmann CC. Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmet Sci 2000; 22:271-283.
85. Hagedorn-Leweke U, Lippold BC. Accumulation of sunscreens and other compounds in keratinous substrates. Eur J Pharm Biopharm 1998; 46:215-221.
86. Müller RH, Wissing SA, Mäder K. Sunscreens containing UV radiation reflecting of absorbing agents, protecting against harmful UV radiation and reinforcing the natural skin barrier. PCT Int Appl WO 01/03652, 2001.
87. Hommoss A, Souto EB, Müller RH. Assessment of the release profiles of a perfume incorporated into NLC dispersions in comparison to reference nanoemulsions. In: AAPS annual meeting and exposition, Nashville, U.S.A., November 2005:6-10.
88. Yaziksiz-Iscan Y, Wissing SA, Müller RH, Hekimoglu S. Different production methods for solid lipid nanoparticles (SLN) containing the insect repellent DEET. In: Proceedings of the fourth world meeting APGI/APV, Florence, 2002:789-790.
89. Yaziksiz-Iscan Y, Hekimoglu S, Sargon MF, Kas S, Hincal AA. In vitro release and skin permeation of DEET incorporated solid lipid nanoparticles in various vehicles. In: Proceedings of the fourth world meeting APGI/APV, Florence, 2002:1183-1184.
90. Yaziksiz-Iscan Y, Wissing SA, Hekimoglu S, Müller RH. Development of a novel carrier system for vitamin K using solid lipid nanoparticles (SLN(tm)). In: Proceedings of the fourth world meeting APGI/APV, Florence, 2002:787-788.
91. Müller RH, Lippacher A, Gohla S. Solid lipid nanoparticles (SLN ) as carrier system for the controlled release of drugs. In: Wise D, ed. Handbook of Pharmaceutical Controlled Release Technology. New York: Marcel Dekker, 2000:377-391.
92. Schneppe T. Entwicklung und Qualifizierung einer Pilotanlage zur GMP- und QMgerechten Herstellung von festen Lipid-Nanopartickeln. Ph.D. Thesis. Berlin: Freie Universität Berlin, 1998.